Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Arterial Hypertension

Explore clinical trials studying Pulmonary Arterial Hypertension. Study availability and eligibility vary by location and protocol.

358 public trials 47 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Arterial Hypertension trial results

Active, not recruiting

An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH)

NCT05649748

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • USA005 Jacksonville, Florida, United States
  • USA011 Tampa, Florida, United States
  • USA006 Chicago, Illinois, United States
  • USA001 Chicago, Illinois, United States
View all 45 locations
View Trial Details
Active, not recruiting

Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)

NCT04816604

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • University of California, Davis Medical Center Sacramento, California, United States
  • Medical Corporation Santa Barbara, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Cleveland Clinic Florida Weston, Florida, United States
View all 28 locations
View Trial Details
Active, not recruiting

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

NCT06274801

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • Valley Advanced Lung Diseases Institute Fresno, California, United States
  • Department of Veterans Affairs Greater Los Angeles Healthcare System Los Angeles, California, United States
  • UC Davis Health Medical Center Sacramento, California, United States
  • Stanford Healthcare Stanford, California, United States
View all 115 locations
View Trial Details
Active, not recruiting

ADAPT - A Patient Registry of the Real-world Use of Orenitram®

NCT03045029

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • University of California - San Francisco Fresno, California, United States
  • University of Southern California - Keck Medical Center Los Angeles, California, United States
  • Paloma Medical Group San Juan Capistrano, California, United States
  • Santa Barbara Pulmonary Associates Santa Barbara, California, United States
View all 41 locations
View Trial Details
Active, not recruiting

A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD

NCT04691154

Conditions
Hypertension, Pulmonary, Lung Diseases, Pathologic Processes, +6 more
Locations
  • Arizona Pulmonary Specialists Scottsdale, Arizona, United States
  • VA Greater Los Angeles Healthcare Los Angeles, California, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • University of South Florida Tampa, Florida, United States
View Trial Details

Related conditions